News
As FDA Delays Novavax' COVID Vaccine Approval, Patients Fight Back
Novavax has been available since 2022 through a pandemic-era Emergency Use Authorization. A decision on full approval – which rival mRNA shots from Moderna and Pfizer and its partner BioNTech already have - was due from the Food and Drug Administration by April 1, but had been delayed by the FDA without explanation.
Journalist Sharyl Attkisson shared a study published in Scientific Reports on COVID-19 deaths, and things are not as they seem.
A new study concludes excess deaths increased in Japan during the COVID-19 pandemic but does not report any explosion in ...
Covid.gov and covidtests.gov were established during the COVID-19 pandemic as resources for the public to order tests and ...
A U.S. Customs and Border Protection officer was arrested after he allegedly used two sham businesses to illegally request ...
Indonesian photographer Joshua Irwandi captured one of the most chilling and poignant images of Covid-19's toll.
Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...
While the Trump administration is focused on cutting costs, addressing the gaps in care for millions of Americans with ...
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
She describes a frustrating year-long wait just to get a fibromyalgia diagnosis and continues with tests to determine if she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback